Advantages at a glance
- Pool of 80 peptides
- Purity: Each peptide ESI-MS checked, pool is purified by solid phase extraction.
- Amount: 25µg each peptide (2mg for complete pool)
- UniProt ID: P0DTC2
- Free shipping
- Shipping within 24h
- 30 days money back guarantee
- Purchase comfortable on account
Product information "Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein)"
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2.
The peptides of this product are supplied lyophilized as trifluoro
acetate salts.
This pool consists of 80 peptides of the spike protein and covers only
the mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529).
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.
Peptide sequences - total length: 1273 amino acids
DLFLPFFSNVTWFHV; RQIAPGQTGNIADYN; VAVLYQGVNCTEVPV; PFFSNVTWFHVISGT; PGQTGNIADYNYKLP; YQGVNCTEVPVAIHA; NVTWFHVISGTNGTK;
GNIADYNYKLPDDFT; QTRAGCLIGAEYVNN; FHVISGTNGTKRFDN; DFTGCVIAWNSNKLD; GCLIGAEYVNNSYEC; VLPFNDGVYFASIEK; CVIAWNSNKLDSKVS;
GAEYVNNSYECDIPI; NDGVYFASIEKSNII; WNSNKLDSKVSGNYN; AGICASYQTQTKSHR; YFASIEKSNIIRGWI; KLDSKVSGNYNYLYR; ASYQTQTKSHRRARS;
IEKSNIIRGWIFGTT; KVSGNYNYLYRLFRK; TQTKSHRRARSVASQ; CEFQFCNDPFLDHKN; FERDISTEIYQAGNK; SHRRARSVASQSIIA; FCNDPFLDHKNNKSW;
ISTEIYQAGNKPCNG; LLLQYGSFCTQLKRA; PFLDHKNNKSWMESE; IYQAGNKPCNGVAGF; YGSFCTQLKRALTGI; DGYFKIYSKHTPIIV; GNKPCNGVAGFNCYF;
CTQLKRALTGIAVEQ; KIYSKHTPIIVREPE; CNGVAGFNCYFPLKS; KRALTGIAVEQDKNT; KHTPIIVREPEDLPQ; AGFNCYFPLKSYSFR; QVKQIYKTPPIKYFG;
IIVREPEDLPQGFSA; CYFPLKSYSFRPTYG; IYKTPPIKYFGGFNF; EPEDLPQGFSALEPL; LKSYSFRPTYGVGHQ; PPIKYFGGFNFSQIL; RFPNITNLCPFDEVF;
SFRPTYGVGHQPYRV; YFGGFNFSQILPDPS; ITNLCPFDEVFNATR; TYGVGHQPYRVVVLS; IAARDLICAQKFKGL; CPFDEVFNATRFASV; GHQPYRVVVLSFELL;
DLICAQKFKGLTVLP; NCVADYSVLYNLAPF; NKCVNFNFNGLKGTG; AQKFKGLTVLPPLLT; DYSVLYNLAPFFTFK; NFNFNGLKGTGVLTE; KGLTVLPPLLTDEMI;
LYNLAPFFTFKCYGV; NGLKGTGVLTESNKK; STASALGKLQDVVNH; APFFTFKCYGVSPTK; PGTNTSNQVAVLYQG; ALGKLQDVVNHNAQA; GDEVRQIAPGQTGNI;
TSNQVAVLYQGVNCT; LQDVVNHNAQALNTL; VNHNAQALNTLVKQL; AQALNTLVKQLSSKF; NTLVKQLSSKFGAIS; KQLSSKFGAISSVLN; SKFGAISSVLNDIFS;
AISSVLNDIFSRLDK; VLNDIFSRLDKVEAE; IFSRLDKVEAEVQID
| Gene: | S | |
| No Peptides: | 80 peptides | |
| Amount Peptide: | 25 µg | |
| Amount Aliquote: | 2,0 mg | |
| Uniprot Id: | P0DTC2 | |
| Solubility: | Dissolve in a minimum amount of pure DMSO (approx. 40μl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological | |
| Storage: | Store at -20°C | |
| Delivery: | 2-3 days | |
| Purity: | Each peptide ESI-MS checked, pool is purified by solid phase extraction | |
| Counter Ion: | TFA | |
| Protein: | Spike glycoprotein | |
| Species: | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) | |
| Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
| Indication : | Covid-19, Infection, Respiratory infection |
Application:
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune responseSource:
syntheticClassification:
Documents:
CertificateProduct description
Accessory Items
This peptide pool of the omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) that covers the whole spike glycoprotein with all mutations. Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.The peptides of this product are supplied lyophilized as trifluoro acetate salts. Peptide Scan 15/11Length: 1270 amino acidsMFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLKSYGFQPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT